Dimitar Deliyski, a pioneer and international leader in the field of voice and speech disorders, has been awarded the designation of MSU Foundation Professor, the first for the College of Communication Arts and Sciences. Deliyski recently was named Chair of the Department of Communicative Sciences and Disorders. His appointment became effective Aug. 16, 2015.
The MSU Foundation Professor title is bestowed by MSU, with support from the MSU Foundation, as part of a new initiative to attract and retain top researchers critical to meeting the strategic initiatives of the university.
“The MSU Foundation Professors program helps the university compete for the best talent with a designation that is comparable to an endowed chair,” said MSU President Lou Anna K. Simon.
Deliyski comes to MSU from the Cincinnati Children’s Hospital Medical Center where he served as the Cotton Chair of Otolaryngology Research and Associate Director of the Communication Sciences Research Center. He also held academic appointments with the University of Cincinnati as a tenured Associate Professor in Otolaryngology - Head and Neck Surgery and affiliated Associate Professor in Communication Sciences and Disorders, and he served as an Adjunct Professor with the Interdisciplinary Mathematics Institute at the University of South Carolina - Columbia.
"Dimitar is a great addition to our faculty,” said Prabu David, Dean of the College of Communication Arts and Sciences. “He is an eminent researcher who is an asset to CSD and I am confident that he will play a key role in increasing interdisciplinary collaborations between our college and other units on campus."
A native of Bulgaria, Deliyski received his Ph.D. in Signal Processing from the Bulgarian Academy of Sciences in Sofia, Bulgaria, in 1990. He completed a postdoctoral fellowship in Communication Sciences and Disorders at the University of Memphis in 1990-1992. Deliyski has a master’s and bachelor’s degree in Computer Science from Sofia Technical University, also in Sofia, Bulgaria.
Deliyski has an extensive publication record and is an international leader in laryngeal imaging and vocal analysis research.
His research interests have focused on improving the clinical assessment of voice and speech disorders, refining our understanding of the mechanisms of voice production, creating new methods for computer imaging of the vocal folds and for acoustic analysis of voice and speech, and improving the methods for speech recognition.
His research in human laryngeal imaging earned him the Manuel Garcia Prize at the World Congress of the International Association of Logopedics and Phoniatrics in 2010.
As a MSU Foundation Professor, Deliyski will receive five years of supplemental research support and will hold the MSU Foundation Professor designation permanently.
Administered through the MSU Office of Research and Graduate Studies, the MSU Foundation Professor program is made possible with support from the MSU Foundation, Office of the Provost and the faculty member’s academic unit.
“MSU Foundation Professorships demonstrate the university’s commitment to invest in our outstanding faculty scholars and support their continued research trajectory,” said MSU Provost June Youatt.
Deliyski was able to attract funding for his research from the National Institute of Health as early as 1995 and has maintained continuous funding to date from various agencies and private entities, including the U.S. Army, U.S. Air Force, American Speech-Language-Hearing Association (ASHA), Agency for Healthcare Research and Quality (AHRQ), and Institute of Laryngology and Voice Restoration (ILVR).
For 10 years (1992-2002), Deliyski served as the Chief Scientist of two leading companies in medical instrumentation and speech technology – KayPentax of Lincoln Park, N.J., and VocalPoint Technologies of San Francisco, Calif.
“That was an unusual start of a scholarship, which allowed me to implement in the clinical practice many of my own, as well as other scholars’, scientific ideas,” Deliyski said. “Thus, I had the unique opportunity to translate research to directly change clinical practice on a worldwide scale, which consequently positioned me as an internationally recognized leader very early in my scientific and professional life.”
At KayPentax (now Pentax Medical Company, Montvale, N.J.), Deliyski led research and developed products that have become the industry standard for assessment and treatment of voice disorders globally. As the Principal Scientist at VocalPoint (now Nuance Communications in Burlington, Mass.), he played a key role in a technology start-up company, including leading their research, securing research funding, and venture capital.Share via these networks: